Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05228457 · ClinicalTrials.gov registry record · NA
Intensive TMS for Bipolar Depression
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05228457: Completed NA study, sponsored by University of Pennsylvania.
NCT05228457 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05228457, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The research study is being conducted to test whether using high dose spaced theta-burst rTMS (a form of transcranial magnetic stimulation) produces a significant reduction in depressive symptoms compared with sham. This project will recruit patients aged 18-70 with symptoms of bipolar depression who have failed (or not shown signs of improvement) after at least two prior treatments.
Interventions
- DEVICE Intensive intermittent theta-burst stimulation (iTBS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2024-02-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05228457
The ClinicalTrials.gov registry entry for NCT05228457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intensive intermittent theta-burst stimulation (iTBS) is the first listed.
NCT05228457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05228457 about?
NCT05228457 is a clinical study titled "Intensive TMS for Bipolar Depression". The research study is being conducted to test whether using high dose spaced theta-burst rTMS (a form of transcranial magnetic stimulation) produces a significant reduction in depressive symptoms compared with sham. This project will recruit patients aged 18-70 with symptoms of bipolar depression wh...
What is the current status of trial NCT05228457?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-03-01. Estimated completion is 2024-02-19.
What interventions are being tested in trial NCT05228457?
The interventions under investigation include: Intensive intermittent theta-burst stimulation (iTBS) (DEVICE).
Who is sponsoring clinical trial NCT05228457?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.